TrialHaematologica2013

Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement.

Shira Dinner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.